Rainbow Children's Medicare Limited (NSE:RAINBOW) filed the transcript of its Q1 FY27 earnings conference call, held on July 31, 2026, pursuant to Regulation 30 of the SEBI LODR Regulations, 2015. The call disclosed revenue growth of approximately 33% year-on-year for the quarter ended June 30, 2026.
Key Highlights
- Revenue grew approximately 33% year-on-year in Q1 FY27, with EBITDA rising 29.9% year-on-year, supported by operating discipline across mature and newly commissioned hospitals.
- Total bed capacity increased 26% year-on-year to 2,435 beds, while operational bed capacity rose 22% to 1,862 beds over the same period.
- The company signed a definitive agreement for a 100-bed brownfield hospital in Malad, Mumbai, marking its entry into Western India, with operations expected in Q1 FY28.
- Management outlined a five-year plan to add 2,500 beds, targeting a total network capacity of 5,000 beds through an estimated capital expenditure of approximately Rs 2,200 crore.
About the Company
Rainbow Children's Medicare Limited (NSE:RAINBOW), headquartered in Banjara Hills, Hyderabad, Telangana, is a paediatric and women's healthcare provider operating under the Rainbow Children's Hospital and BirthRight by Rainbow Hospitals brands. The company offers child care, women care, and fertility services across locations including Hyderabad, Bengaluru, Chennai, Delhi, Visakhapatnam, Vijayawada, Rajahmundry, Warangal, and Guwahati.
Announcement in Detail
The transcript, filed by Company Secretary Shreya Mitra on August 4, 2026, covers a call moderated by Rahul Jeewani of IIFL Capital and hosted by senior management including Chairman and Managing Director Dr. Ramesh Kancharla, Group CEO Abrarali Dalal, and Group CFO Vikas Maheshwari. Inpatient discharges grew 28%, outpatient consultations rose 25%, and deliveries increased 23% year-on-year in Q1 FY27. Occupancy improved to over 41%, with a 6% improvement in average revenue per occupied bed.
Beyond the quarter, the company confirmed the acquisition of the 70-bed Prime Children's Hospital in Nellore, Andhra Pradesh, along with a 30-bed Maternal Care Block expected to begin operations within six months. A long-term lease for a 50-bed hospital in Guntur was also signed. Upcoming openings include the Indore hospital in Q3 FY27, regional hub hospitals in Coimbatore and a spoke in Gurgaon Sector 56 in Q3 FY28, and a hub in Gurgaon Sector 44 in Q1 FY29.
Impact on Investors
The filing shows the company has disclosed visibility of approximately 1,200 beds already under various stages of development toward its 5,000-bed target. Investors will note that the Rs 2,200 crore capex plan represents a material capital commitment over five years, which the company states will be funded from its existing balance sheet strength. The disclosed terms indicate that execution timelines for new hospitals are staggered across FY27 to FY29, which shareholders will observe introduces phased revenue contribution rather than immediate impact.
Investors will note that the Mumbai entry through the Malad brownfield agreement marks a geographic diversification beyond the company's established Southern India base, with management stating it sees significant long-term opportunities in the Western India market, as disclosed in the call transcript.
Sector / Market Context
India's healthcare infrastructure continues to see rising demand for specialised paediatric and maternal care services. The National Health Policy targets increasing public health expenditure, and private hospital operators have been expanding capacity in tier-1 and tier-2 cities. The paediatric hospital segment remains concentrated, with Rainbow among the few organised chains operating at scale in this specialty.